Related Experiment Video
Updated: May 3, 2026

06:26
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
6.4K
The Proximal Lilly Collection: Mapping, Exploring and Exploiting Feasible Chemical Space
Christos A Nicolaou1, Ian A Watson1, Hong Hu1
1Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company , Indianapolis, Indiana 46285, United States.
Journal of Chemical Information and Modeling
|June 11, 2016
Summary
The Proximal Lilly Collection (PLC) defines synthesizable small molecules for drug discovery. This initiative uses chemoinformatics to create a feasible virtual compound library, aiding researchers in identifying novel drug candidates like selective kinase inhibitors.
Area of Science:
- Medicinal Chemistry
- Chemoinformatics
- Drug Discovery
Background:
- Exploring vast chemical space for novel small molecules is crucial but challenging.
- Synthesizability of in silico-designed compounds remains a practical obstacle.
- Existing methods often struggle with the sheer number of theoretically possible compounds.
Purpose of the Study:
- To define and provide access to a virtual collection of synthesizable, drug-like small molecules.
- To leverage in-house synthetic knowledge and resources for drug discovery.
- To facilitate exploration of feasible chemical space for identifying novel therapeutics.
Main Methods:
- Implementation of the Proximal Lilly Collection (PLC) initiative.
- Coupling synthetic knowledge with chemo/reaction informatics tools.
- Development of a computational framework for managing a virtual compound collection.
Main Results:
- Creation of a large, realistically feasible virtual collection of drug-like compounds.
- Demonstration of the PLC's utility through the discovery of selective kinase inhibitors.
- Facilitation of drug discovery research by providing accessible virtual compound libraries.
Conclusions:
- The PLC initiative successfully addresses the challenge of synthesizability in virtual screening.
- Accessible, feasible virtual collections significantly enhance drug discovery efforts.
- This approach enables the identification of novel drug candidates, exemplified by kinase inhibitors.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K

